Therapeutic time window important factor for cord blood cell transplantation after stoke

October 1, 2012

A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within 72 hours of the stroke. Their study is published in the current issue of Cell Transplantation (21:6), now freely available on-line.

" is one of the most frequent causes of death and the most common reason for permanent disabilities in adults in industrialized nations," said Dr. Johannes Boltze, study corresponding-author from the University of Leipzig. "Despite recent research, treatment opportunities are limited and the only approved therapy to date must be administered within a narrow four and a half hour ."

According to the authors there is a "strong demand for alternative strategies," and among those most recently studied is using neonatal or . Their study investigates the time-dependent efficacy of hUCB MNCs following experimental brain ischemia in rats. The emphasis of their study was exploring factors that impact on Cell Transplantation to derive the best outcomes, such as determining an appropriate transplantation time point, or window of opportunity.

The researchers transplanted hUCB MNCs into test animals at various time intervals following stroke, at four hours, 24 hours, 72 hours, 120 hours and at 14 days.

"Our results demonstrated that transplantation within a 72 hour time window resulted in an early improvement in functional recovery," said Dr. Boltze.

"The failure to induce sustained functional recovery, lesion reduction, and limitation of glial scaring in animals treated at 120 hours indicates the 72 hour time window as efficient for cell application."

The authors noted that administration of hUCB MNCs within the 72 hour window resulted not only in but also a reduction in and in diminished glial scaring demonstrating the importance of this factor on the impact of umbilical cord blood Cell Transplantation. Later transplantation, at 14 days, showed no benefit.

"Our study shows that hUCB MNCs are a promising tool for acute stroke treatment, but require a comparatively early intervention in the subacute phase of ," concluded the authors.

"This research adds to a growing body of evidence supporting specific early time periods for repair of the brain, spinal cord, heart and other organs following acute injury and is very important in the development of regenerative therapies" said Dr. Paul R. Sanberg, Distinguished Professor of Neurosurgery and Brain Repair at the University of South Florida.

Explore further: Study finds cryopreserved endothelial progenitor cells phenotypically identical to non-frozen

More information: Boltze, J.; Schmidt, U. R.; Reich, D. M.; Kranz, A.; Reymann, K. G.; Strassburger, M.; Lobsien, D.; Wagner, D.-C.; Förschler, A.; Schäbitz, W.-R. Determination of the Therapeutic Time Window for Human Umbilical Cord Blood Mononuclear Cell Transplantation Following Experimental Stroke in Rats. Cell Transplant. 21(6):1199-1211; 2012. http://www.ingentaconnect.com/content/cog/ct/

Related Stories

Study finds cryopreserved endothelial progenitor cells phenotypically identical to non-frozen

May 11, 2011
A study published in the current issue of Cell Transplantation has demonstrated for the first time that endothelial cells derived from cryopreserved human umbilical cord blood cells are phenotypically, as well as structurally ...

Neural stem progenitor cell transplantation’s potential to aid spinal cord injury tested

July 11, 2011
A study published in the current issue of Cell Transplantation (20:5) investigating optimal routes for transplanting neural stem/progenitor cells (NS/PCs) in animal models of spinal cord injury (SCI) has demonstrated that ...

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.